Skip to main content

Year: 2025

Oxford Square Capital Corp. Announces Offering of Notes

GREENWICH, Conn., July 31, 2025 (GLOBE NEWSWIRE) — Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQG) (NasdaqGS: OXSQZ) (the “Company”) today announced the commencement of a registered public offering of notes (the “Notes”). The public offering price and other terms of the Notes are to be determined by negotiations between the Company and the underwriters. The Company also plans to grant the underwriters a 30-day option to purchase additional Notes on the same terms and conditions to cover over-allotments, if any. The Notes are expected to be listed on the NASDAQ Global Select Market and to trade thereon within 30 days of the original issue date. The Company expects to use the net proceeds from this offering to repay indebtedness, acquire investments in accordance with its investment objective and strategies and for...

Continue reading

Namib Minerals Provides Corporate Update

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — Namib Minerals (“Namib Minerals” or “the Company”), (Nasdaq: NAMM), an established African gold producer with a portfolio of mining and exploration assets in Zimbabwe and the Democratic Republic of Congo, is pleased to provide a corporate update after closing the business combination with Hennessy Capital Investment Corp. VI and listing on the Nasdaq Stock Exchange under the ticker symbol NAMM. The Company also recently rang the Closing Bell at the Nasdaq Stock Exchange on July 25, 2025. Namib Minerals Rings the Nasdaq Closing Bell Photo Courtesy of Nasdaq, Inc. Ibrahima Sory Tall, Chief Executive Officer, stated “This achievement marks more than a change in our corporate structure – it is a validation of our vision. The transaction facilitates access to strategic partnerships necessary...

Continue reading

Discovery Announces Senior Management Appointment

TORONTO, July 31, 2025 (GLOBE NEWSWIRE) — Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) today announced the appointment of Alison White to the position of Chief Financial Officer (“CFO”). The appointment is effective immediately. Tony Makuch, Discovery’s CEO, commented: “We are very pleased to welcome Alison to Discovery’s leadership team. She brings extensive and diverse experience in both finance and operations that will prove beneficial as we invest to grow and create value for all stakeholders. In particular, Alison’s experience in CFO roles with SSR and, prior to that, Newmont provided her with significant knowledge that will be extremely helpful as we pursue the tremendous opportunities that exist to improve and grow our Porcupine Operations. Together, the Discovery team is driven to re-establish...

Continue reading

Nuvectis Pharma Provides Final Clinical Data Update from the NXP800 Phase 1b Study in Ovarian Cancer and Reports Completion of the NXP900 Phase 1a Dose Escalation Study

Available data from 13 patients with recurrent, platinum resistant, ARID1a-mutated ovarian cancer treated with 75 mg/day in the NXP800 Phase 1b study includes 2 partial responses and 3 stable diseases; thrombocytopenia successfully managed with intermittent dosing schedule; observed clinical activity warrants exploration of potential development opportunities in other cancer typesNXP900 successfully completed a clinical drug-drug interaction (DDI) study in healthy volunteers and the Phase 1a dose escalation study; initiation of the NXP900 Phase 1b program to evaluate the safety and efficacy of NXP900 as a single agent and in combination with other anti-cancer agents expected in the coming weeksFort Lee, NJ, July 31, 2025 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT), a clinical stage biopharmaceutical company focused...

Continue reading

Lifeist’s Mikra Cellular Sciences Targets Athletes Through Strategic Partnership with the ASICS Runkeeper app and Race Roster

Collaboration to cost-efficiently advance Mikra’s Mind-First Movement and customer acquisition strategy through direct contact with athletes seeking to elevate mental clarity, focus on endurance TORONTO, July 31, 2025 (GLOBE NEWSWIRE) — Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSX.V: LFST; OTCQB: LFSWF; FRANKFURT: M5B0) announced a strategic partnership signed May 26, 2025 between its wholly owned subsidiary Mikra Cellular Sciences and two leading fitness platforms: the globally recognized ASICS Runkeeper app and premier North American race registration platform Race Roster. This collaboration represents a significant milestone in Mikra’s Mind-First Movement by directly engaging athletes actively seeking mental clarity, focus, and endurance to enhance overall performance. In June, Mikra launched an exclusive program...

Continue reading

Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Completed Merger with GlycoMimetics and Previously Announced $200 Million Private Financing Supporting Pipeline of Next Generation Therapeutics for Solid Tumors Recent Leadership Appointments Bring Deep Experience in Oncology Drug Development, Clinical Operations and Building Biotechnology Companies On Track to Submit IND Application for CR-001, a PD-1 x VEGF Bispecific Antibody, in Fourth Quarter of 2025, with Proof-of-Concept Clinical Data Expected in Second Half of 2026 WALTHAM, Mass., July 31, 2025 (GLOBE NEWSWIRE) — Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced financial results for the second quarter ended June 30, 2025, and recent business highlights. “The second quarter of 2025...

Continue reading

FOXO TECHNOLOGIES INC. ANNOUNCES LICENSE RENEWAL AND PROVIDES OPERATIONAL UPDATE FOR MYRTLE RECOVERY CENTERS, INC.

WEST PALM BEACH, FLORIDA, July 31, 2025 (GLOBE NEWSWIRE) — FOXO Technologies, Inc., (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that its behavioral health subsidiary, Myrtle Recovery Centers, Inc., has renewed its operating license for its Oneida, TN location for another year. The license renewal to operate an alcohol and drug residential treatment facility was granted by the State of Tennessee’s Department of Mental Health and Substance Abuse Services after a successful annual inspection. Robert Merritt, CEO of Myrtle Recovery Centers, Inc. noted, “We are pleased that the state renewed our operating license for another year. Currently, the facility is at full capacity, and we are managing a waiting list for future admissions.” “We are leveraging the success of Myrtle’s first operating location through active...

Continue reading

Flow Capital Announces a C$15.0M Investment in Common Wealth

TORONTO, ON, July 31, 2025 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV: FW) (“Flow Capital” or the “Company”) is pleased to announce a C$15.0 million senior secured note in Common Wealth Pension Services Inc. (dba “Common Wealth”), a SaaS company serving the Canadian group retirement market, with a first tranche advance of C$4.0 million. Common Wealth offers a modern full-stack platform for group retirement plan administration. With a user-friendly interface and expert support, the platform empowers members to build long-term financial security, enables employers of all sizes to offer competitive retirement benefits, and equips advisors with tools to better serve clients and accelerate the growth of their group retirement practices. Flow Capital’s investment will support Common Wealth in accelerating product innovation, expanding...

Continue reading

MariMed’s Products to Enter Pennsylvania Market Through a Management Services and Licensing Agreement with TILT Holdings

NORWOOD, Mass., July 31, 2025 (GLOBE NEWSWIRE) — MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced a strategic agreement with TILT Holdings (“TILT”) (CBOE: TILT) (OTCPK: TLLTF) that will expand the distribution of the Company’s award-winning portfolio of medical marijuana products to Pennsylvania. On July 30, 2025, Standard Farms, LLC (“Standard Farms”), a wholly owned subsidiary of TILT, entered into a Management Services Agreement (the “MSA”) with MariMed Advisors, Inc., a Delaware corporation and wholly owned subsidiary of MariMed (the “Manager”). Under the terms of the MSA, effective September 1, 2025, MariMed will assume the day-to-day management of TILT’s Standard Farms cultivation and processing facility in White Haven, Pennsylvania....

Continue reading

Orrön Energy announces the sale of a 76 MW solar project in Germany

Orrön Energy AB (“Orrön Energy” or “the Company”) is pleased to announce that it has entered into an agreement with Saxovent Renewables to sell a 76 MW solar project in Germany, for a total consideration of MEUR 4.0. The consideration paid at closing is MEUR 2.0, with the remaining consideration contingent upon municipal and legislative approvals. The project is located in the northeastern part of Germany, and is being developed as an agrivoltaic (Agri-PV) project, enabling agricultural activities to take place alongside solar power generation. Half of the total consideration of MEUR 4.0 is paid at closing, which is expected imminently. The contingent consideration of MEUR 2.0 is subject to the fulfilment of two conditions: (i) municipal approval of the zoning plan (Satzungsbeschluss) and (ii) EU Commission approval of the German Solar...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.